Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGeiger Counter Regulatory News (GCL)

Share Price Information for Geiger Counter (GCL)

Share Price is delayed by 15 minutes
Get Live Data
72.50    -0.10 (-0.14%)
Bid:
71.00
Ask:
74.00
Spread: 3.00 (4.225%)
Market Cap: £91.21m
GCL Live PriceLast checked at - London Stock Exchange

Intraday Geiger Counter Share Chart

Annual Overview from QuotedData

10 Jul 2025 14:48

RNS Number : 6102Q
Geiger Counter Ltd
10 July 2025
 

Geiger Counter Limited - Annual Overview from QuotedData

10th July 2025

Enriched prospects

A commitment to quadruple nuclear generating capacity in the US, made by President Donald Trump in a series of executive orders signed at the end of May, has provided a significant and much-needed boost to the uranium sector, in which Geiger Counter (GCL) invests. A number of uranium stocks rose by double figures in the days following the pledge to "re-establish the US as a global leader in nuclear energy".

Investor sentiment towards the sector had been waning prior to this, with a number of factors combining to put downward pressure on GCL's net asset value (NAV) (which we explore on page 4). In reality, this was in stark contrast to the fundamentals of the uranium market, which is displaying both demand-side expansion (increasing energy needs, especially from countries seeking lower-emission baseload power) and supply-side constraints. The expertise and long-term track record of GCL's manager, along with the extremely positive market fundamentals, make it an opportune time to invest in the company.

Full Research:

https://quoteddata.com/research/geiger-counter-limited-enriched-prospects-qd/

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note Geiger Counter Limited, and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the Financial Conduct Authority. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.

QUOTEDDATA50 Gresham Street | London EC2V 7AYTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEADXEFLKSEFA
Date   Source Headline
8th Oct 20252:02 pmRNSShare Buyback- Replacement 08/10/2025
8th Oct 20259:59 amRNSShare Buyback
7th Oct 20252:33 pmRNSNet Asset Value(s)
6th Oct 20251:04 pmRNSNet Asset Value(s)
3rd Oct 20254:31 pmRNSNet Asset Value(s)
3rd Oct 202510:19 amRNSNet Asset Value(s)
3rd Oct 202510:05 amRNSNet Asset Value(s): Replacement 01/10/2025
1st Oct 20254:48 pmRNSNet Asset Value(s)
1st Oct 202511:09 amRNSShare Buyback
30th Sep 20252:23 pmRNSNet Asset Value(s)
29th Sep 20253:21 pmRNSNet Asset Value(s)
29th Sep 20257:00 amRNSAdministrator and Company Secretary - Name Change
26th Sep 20254:25 pmRNSNet Asset Value(s)
25th Sep 20253:22 pmRNSNet Asset Value(s)
25th Sep 202510:18 amRNSMonthly Factsheet- August 2025
24th Sep 20253:05 pmRNSNet Asset Value(s)
23rd Sep 20253:34 pmRNSNet Asset Value(s)
22nd Sep 20255:05 pmRNSNet Asset Value(s)
19th Sep 20252:40 pmRNSNet Asset Value(s)
18th Sep 20253:05 pmRNSNet Asset Value(s)
17th Sep 20253:42 pmRNSNet Asset Value(s)
16th Sep 20253:42 pmRNSNet Asset Value(s)
15th Sep 20254:50 pmRNSNet Asset Value(s)
12th Sep 20254:43 pmRNSNet Asset Value(s)
11th Sep 20253:52 pmRNSNet Asset Value(s)
10th Sep 20252:55 pmRNSNet Asset Value(s)
9th Sep 20251:32 pmRNSNet Asset Value(s)
8th Sep 20255:26 pmRNSNet Asset Value(s)
5th Sep 20253:50 pmRNSNet Asset Value(s)
4th Sep 20252:55 pmRNSNet Asset Value(s)
3rd Sep 20251:45 pmRNSNet Asset Value(s)
2nd Sep 20253:07 pmRNSNet Asset Value(s)
1st Sep 20254:42 pmRNSNet Asset Value(s)
29th Aug 20251:44 pmRNSNet Asset Value(s)
28th Aug 20251:53 pmRNSNet Asset Value(s)
27th Aug 20251:46 pmRNSNet Asset Value(s)
26th Aug 20254:31 pmRNSNet Asset Value(s)
22nd Aug 20255:59 pmRNSNet Asset Value(s)
22nd Aug 202511:26 amRNSMonthly Factsheet- July 2025
21st Aug 20251:35 pmRNSNet Asset Value(s)
20th Aug 20251:00 pmRNSNet Asset Value(s)
19th Aug 20253:23 pmRNSNet Asset Value(s)
18th Aug 20252:52 pmRNSNet Asset Value(s)
15th Aug 202512:41 pmRNSNet Asset Value(s)
15th Aug 202510:50 amRNSShare Buyback
14th Aug 202512:05 pmRNSNet Asset Value(s)
14th Aug 20258:58 amRNSShare Buyback
13th Aug 20252:36 pmRNSNet Asset Value(s)
13th Aug 202510:43 amRNSShare Buyback
12th Aug 20253:23 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.